NANJING, CHINA–(Marketwired – Oct 29, 2017) – CloudHealth Medical Group Ltd., a healthcare management company, announced yesterday (October 28, 2017), during the “China-US Precision Medicine Initiatives Summit” and grand opening event of the “National Health Medical Big Data Exhibition Center” in Nanjing, China, the appointment of George M. Church, Ph.D., Professor of Genetics, Harvard Medical School to the company’s scientific advisory board (SAB) to advise on the strategic development of their direct to consumer platform, which will integrate “pan-omics data types” and artificial intelligence, as consumers become more empowered to manage their health than ever before.
“I see more consumers, both healthy and non-healthy people, playing a more proactive role in taking ownership of their own health these days as more information is available at their fingertips and their demand for extremely personalized products based on their genomic and phenotypic data increases,” said Baojun Gao, Chairman of CloudHealth Medical Group. In addition, she added, “We are integrating our real estate and retail experience combined with personal ‘pan-omics’ data to redefine the way we engage with our consumers in terms of increased touch points with improved health outcomes.”
As advances in technology evolve, they are increasingly being adopted into medical device and diagnostic products, and integrated into other business verticals involving nutrition, fitness and the like. “The patient experience is now starting to influence the development of innovative healthcare-related methodologies, products and services that can ultimately lead to better outcomes,” said George Church, Professor of Genetics at Harvard Medical School. “I look forward to seeing the incorporation of the latest disruptive technologies into the evolving consumer-centric models of healthcare,” added Dr. Church.
“I have been in the retail space for many decades and I see consumers are relying more on direct to consumer advertising, the internet and a variety of social media platforms to seek information or answers before seeing a doctor,” said Dickson Setzo, Executive Director of CloudHealth Medical Group. “We are adapting to a paradigm in which consumers are having more influence and control over the products used in their healthcare decisions, but we would like to empower them by making their data more interactive.”
“We are very excited to welcome my friend, mentor and colleague, George Church, a leading expert in the field of genomics and computational integrative medicine, to our newly formed SAB focused on our direct to consumer platform,” said Winston Patrick Kuo, Chief Technology Officer of CloudHealth Genomics. “We look to add additional members, to help develop and improve our platform, to speed up the process of commercializing next-generation products from ‘big-data’, to enable people and patients to have the ability to take their data from a variety of sources, to empower themselves in consuming services or products to enhance their lives.”
“We are well positioned to provide NGS-based consumer products, as CloudHealth Genomics is a global leader and scalable provider of high-quality genomic data, as more and more consumers are being empowered to harness health data for better outcomes,” said Jason Gang Jin, Chief Executive Officer and co-Founder of CloudHealth Medical Group.
About CloudHealth Medical Group, Ltd.
CloudHealth Medical Group, based in Nanjing and Shanghai, is the leading company in China focused on healthcare management, providing pan-omics-based precision medicine and scientific wellness products and solutions. The company prides itself in having a certified clinical genetic testing lab and a high throughput sequencing center. CloudHealth Medical Group ecosystem, comprising of CloudHealth Genomics, CloudHealth Life Center, CloudHealth High-End Clinic Center, CloudHealth Big Data Center, CloudHealth Genomics Research Institute, Academician Experts Workstation and CloudHealth Club of Medical Doctors. For more information, visit http://en.chgenomics.com (English) or www.CHgenomics.com (Chinese).
About Professor George Church
George Church, Ph.D. is a leader in the fields of computational genetics, genomics, bioinformatics, systems biology, bioengineering and technology development. He is a professor of genetics at Harvard Medical School and a professor of health sciences and technology at Harvard and MIT and a founding member of the Wyss Institute for Biologically Inspired Engineering. Dr. Church is director of the U.S. Department of Energy Technology Center, director of the National Institutes of Health Center of Excellence in Genomic Science and director of the Personal Genome Project. He has co-founded nine biotech companies and is a member of the National Academy of Sciences, the National Academy of Engineering and the Franklin Bower Laureate for Achievement in Science. He has coauthored 453 manuscripts, 105 patent publications and one book (Regenesis).